Shivalik Rasayan
- Market cap
- ₹ 490 Cr.
- P/E
- 37x
- P/B
- 1.14x
- 52-week range
- 206.4 – 471
- ROE
- 2%
- ROCE
- 5%
- Dividend yield
- 0.2%
- Debt / equity
- 0.28
- Sector
- Fertilizers & Agrochemicals
- Industry
- Pesticides & Agrochemicals
- Listed on
- NSE, BSE
About
Shivalik Rasayan Limited is an India-based company. The Company’s segments are engaged in agrochemicals, active pharma ingredients (API), and pharma formulation. It is the producer of Malathion Technical and Dimethoate Technical. Malathion Technical is a non-systemic, wide spectrum organophosphorus (OP) based contact insecticide. Dimethoate Technical is used in preparation of formulations used in the control of a range of insects and mites. It also manufactures organophosphorus-based insecticides and chemicals. It has a diverse product range and product mix in order to serve consumer requirements. The APIs are being developed and manufactured in the niche area of oncology, ARVs, cardiovascular, metabolic disorders and immunology. It offers solutions from product selection to development to commercialization for a range of oncology and non-oncology products. The Company’s oncology products include Azacitidine, Busulfan, Bortezomib, and various others.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Pesticides & Agrochemicals: 33 companies →Shivalik Rasayan against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)37 against a typical 23.3: pricier than most peers (1st = cheapest).26th of 33
- Sales growth+7.9% against a typical −4.5% from a year earlier.7th of 31
- Profit growth+59.6% against a typical +15.2% from a year earlier.8th of 25
- Share price, 3 months+22.5% against a typical −15.5%.3rd of 32
- Size₹ 490 Cr. market value against a typical ₹ 883.3 Cr. (1st = largest).20th of 31
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 14 Aug 2026 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2026 |
| 27 May 2026 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2026 and dividend |
| 13 Feb 2026 | Financial Results | To consider and approve the financial results for the period ended December 31, 2025 |
| 14 Nov 2025 | Financial Results | To consider and approve the financial results for the period ended September 30, 2025 |
| 12 Aug 2025 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2025 |
| 30 May 2025 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2025 and dividend |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 67 | 70 | 71 | 75 | 82 | 85 | 69 | 89 | 94 | 82 | 103 | 96 |
| Expenses | 57 | 61 | 62 | 65 | 71 | 72 | 64 | 78 | 82 | 72 | 90 | 85 |
| Operating Profit | 10 | 9 | 9 | 9 | 12 | 13 | 6 | 11 | 12 | 10 | 12 | 11 |
| OPM % | 14.4% | 12.6% | 13% | 12.6% | 14.3% | 15.6% | 8.3% | 12.3% | 12.8% | 12.6% | 12.1% | 11.6% |
| Other Income | 1 | 2 | 1 | 1 | 0 | 2 | 6 | 1 | 0 | 1 | 2 | 1 |
| Interest | 2 | 2 | 3 | 2 | 2 | 2 | 3 | 3 | 2 | 2 | 2 | 2 |
| Depreciation | 3 | 3 | 3 | 4 | 5 | 5 | 3 | 5 | 5 | 5 | 4 | 4 |
| Profit before tax | 5 | 6 | 5 | 5 | 5 | 8 | 6 | 4 | 5 | 4 | 8 | 6 |
| Tax % | 45% | 24.8% | 9.1% | 16.1% | 11.6% | 11.4% | 13.2% | 31.9% | 21.4% | 11.1% | 7.1% | 20.5% |
| Net Profit | 3 | 4 | 5 | 4 | 4 | 7 | 5 | 3 | 4 | 4 | 7 | 5 |
| EPS in Rs | 1.21 | 1.97 | 2.21 | 2.26 | 2.58 | 3.39 | 2.62 | 1.02 | 1.94 | 1.71 | 2.88 | 2.16 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- 13%
- 5 Years
- 13%
- 3 Years
- 16%
- TTM
- 15%
- 10 Years
- 14%
- 5 Years
- −7%
- 3 Years
- −16%
- TTM
- −9%
- 10 Years
- 16%
- 5 Years
- −22%
- 3 Years
- −30%
- TTM
- —
- 10 Years
- 6%
- 5 Years
- 4%
- 3 Years
- 3%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Shivalik Rasayan | ₹ 316.00 | ₹ 490 Cr. | 37x | 1.1x | 2% | — |
| Asian Paints | ₹ 2,305.00 | ₹ 2,21,095 Cr. | 58.1x | 12.1x | 21.2% | 12.4% |
| Solar Industries India | ₹ 18,320.00 | ₹ 1,65,778 Cr. | 99.6x | 26.6x | 31.4% | 17.7% |
| Pidilite Industries | ₹ 1,514.00 | ₹ 1,54,107 Cr. | 64.8x | 14.7x | 23.8% | 16.9% |
| SRF | ₹ 2,309.00 | ₹ 68,444 Cr. | 44.6x | 6.1x | 13.8% | 11.6% |
| Linde India | ₹ 5,697.00 | ₹ 48,586 Cr. | 110.5x | 14.2x | 13.6% | 21.7% |
Management
- Rahul Bishnoi
- Chairman of the Board
- Suresh Kumar Singh
- Whole- Time Vice Chairman of the Board
- Vinod Kumar
- Chief Financial Officer
- Parul Choudhary
- Compliance Officer, Company Secretary
- Vimal Kumar Shrawat
- Managing Director, Non-Independent Executive Director
Prices are delayed and for information only. Nothing on this page is investment advice.